Gx Elite vials are a step up from standard products, performing significantly better in compression and side impact tests
At the recently-held edition of CPhI Worldwide, Gerresheimer had on show its Gx Elite vials which, the company says, set new standards for type 1 borosilicate glass vials.
The Gx Elite vials have – set new standards for type 1 borosilicate glass vials. They are the result of comprehensive optimization measures in the conversion process, which have focused on designing out the risk to create product flaws during production including the removal of all glass-to-glass contact beginning with the tubing material all the way through final packaging. The chemical composition of the borosilicate glass is still the same. Gerresheimer showcased Gx Elite vials at CPhI Worldwide.
“Our Gx Elite vials are setting new standards when it comes to quality,” says Jens Heymann, Senior Vice President Europe & Asia Tubular Glass at Gerresheimer, underlining the major difference that avoiding glass-to-glass contact in the production process can have on vial quality. The highly shatter-resistant vials are extremely durable and free of cosmetic defects. They also boast an incredibly robust structure, while their resistance to delamination protects the drug inside. Simple handling and a range of packaging options ensure that Gx Elite vials can be supplied for end-to-end use on various filling lines. For customers, this means lower costs and higher quality.
All of Gerresheimer’s tubular glass plants that produce vials work with standardized monitoring, inspection, and packaging technologies, which essentially comprise the Gx G3 and Gx RHOC systems. The inspection systems, for one, are developed in house and form part of a close-knit testing system that ensures the highest precision and quality assurance in line with the latest standards. Complete with five HD cameras, the Gx G3 inspection system makes sure that cosmetic defects are identified reliably, for instance. The intelligent software detects and classifies the defects in a few fractions of a second, while the Gx RHOC system ensures dimensional quality with three HD matrix cameras on each side and a hypercentric ID camera.
Injection vials set the benchmark for primary packaging for parenteral drugs. Gerresheimer’s come in all sizes and comply with the relevant international standards and pharmacopoeias (EU, USP, JP). The company’s range includes solutions for bioengineered drugs and other specialist pharmaceuticals.
Gerresheimer is a leading global partner to the pharma and healthcare industry. With specialty glass and plastic products, the company contributes to health and well-being. Gerresheimer operates worldwide and its approximately 10,000 employees manufacture products in local markets, close to its customers. With plants in Europe, North America, South America, and Asia, it generates revenues of approximately EUR 1.4 billion. The company’s comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: insulin pens, inhalers, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.